ESMO Preceptorship on Non-Small-Cell and Small-Cell Lung Cancer 2024: Singapore

Learning objectives

• To learn about best clinical practice in the management of NSCLC in early, locally advanced and metastatic stages
• To learn about the management of patients with actionable driver alterations and novel targeted agents for advanced NSCLC
• To understand the role of immune checkpoint blockade for lung cancer and to learn about novel immunotherapies
• To learn about the systemic treatment of SCLC

Download the preliminary programme

Co-Chairs

• Tony S. K. Mok, Hong Kong, SAR China
• Solange Peters, Switzerland

How to apply

Application is via online form. During the application process you will be required to upload the following:

• Your CV including a list of your publications
• 3-5 slides presenting a clinical case (please use the ESMO Preceptorship Case Presentation Power Point template, provided here)

Application deadline

Application deadline has now closed.

Who can apply?

While this course is primarily aimed at oncologists resident in the Asia-Pacific region, application is open to all ESMO members.

To apply, ESMO membership is mandatory. If you are not an ESMO member or need to renew your membership, please visit the ESMO membership pages.

What's included?

Successful applicants will benefit from complimentary registration and accommodation.

Travel grant

In addition to the course registration and the hotel accommodation, a travel grant of maximum 600 euros is offered to selected applicants as a contribution versus their travel costs. The reimbursement will be processed after the course against original invoices/vouchers. Please be aware that visa costs are NOT covered by the travel grant and are the participant's responsibility.

Accreditation

The programme of this event will be accredited with 9 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Health and Safety Policy

It is each participant’s responsibility to check and comply with the latest health and travel regulations to ensure a smooth and safe journey from the Country of origin to the event venue, and back.

During the event, ESMO will apply health and safety protocols according to the latest local authority guidelines and regulations.

In general, ESMO recommends

• to apply health precautions and measures according to formal guidance and personal medical history
• to stay up to date with the vaccination status
• to perform a Rapid Antigen Test and wear a mask in case of symptoms

Hand sanitisers will be available throughout the venue; the use of mask is at own discretion in the absence of symptoms.

Any changes to the ESMO health and safety protocols will be communicated on this webpage.

Insurance

ESMO bears no responsibility for any untoward events in connection with, before, during and after the course. Participants are strongly advised to take out their own personal and travel coverage.

Venue

Singapore, Republic of Singapore